Ethics Opinions

Consideration of the gestational carrier: an Ethics Committee opinion (2023)

Intended parents engage with gestational carriers (GCs) to achieve their personal reproductive goals.

Ethics Committee Document

Publication DateJanuary 10, 2023

View the Report

Updated terminology for gamete and embryo donors: directed (identiﬁed) to replace ‘‘known’’ and nonidentiﬁed to replace ‘‘anonymous’’: a committee opinion (2022)

The American Society for Reproductive Medicine encourages all stakeholders with an interest in gamete and embryo donation to adopt directed (identiﬁed) in lieu of ‘‘known’’ and nonidentiﬁed in

Ethics Committee Document

Publication DateAugust 17, 2022

View the Report

Human immunodeﬁciency virus and infertility treatment: an Ethics Committee opinion (2021)

Human Immunodeﬁciency Virus is a serious but manageable chronic disease that affects persons of reproductive age, many of whom express a desire for biological parenthood.

Ethics Committee Document

Publication DateApril 30, 2022

View the Report

Cross-border reproductive care: an Ethics Committee opinion (2022)

Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care, what harms and benefits may result, and

Ethics Committee Document

Publication DateFebruary 23, 2022

View the Report

Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)

Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community. During such crises, physicians should ensure

Ethics Committee Document

Publication DateFebruary 09, 2022

View the Report

Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion (2022)

It is ethically appropriate for providers to treat women who are at elevated risk provided that the women are carefully assessed, that specialists in their medical condition are consulted as

Ethics Committee Document

Publication DateJanuary 31, 2022

View the Report

Use of reproductive technology for sex selection for nonmedical reasons: an Ethics Committee opinion (2022)

Because the practice of preimplantation sex selection is ethically controversial, clinics are encouraged to develop and make available their policies regarding its use. Practitioners offering

Ethics Committee Document

Publication DateJanuary 31, 2022

View the Report

Ethical issues in oocyte banking for nonautologous use: an Ethics Committee opinion (2021)

At a minimum, all medical guidelines applicable to women donating fresh (non-cryopreserved) oocytes should also apply to women donating oocytes to an oocyte (egg) bank. These include informed

Ethics Committee Document

Publication DateSeptember 01, 2021

View the Report

Moving innovation to practice: an Ethics Committee opinion (2021)

The introduction of new strategies, tests, and procedures into clinical practice raises challenging ethical issues involving evaluation of evidence, balancing benefits and harms, supporting

Ethics Committee Document

Publication DateAugust 01, 2021

View the Report

Financial compensation of oocyte donors: an Ethics Committee opinion (2023)

Financial compensation of women donating oocytes for reproductive or research purposes is justiﬁed on ethical grounds and should acknowledge the time, inconvenience, and discomfort associated

Ethics Committee Document

Publication DateAugust 01, 2021

View the Report

Ethics Committee Opinions